Assessment of orocaecal transit time in different localization of Crohn's disease and its possible influence on clinical response to therapy

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 1, 2003, Pages 69-74

  Tursi, Antonio ^a,d   Brandimarte, Giovanni ^b   Giorgetti, GianMarco ^c   Nasi, Gabriella ^b  

^a 'Lbonomo' Hospital   (Italy)

^b 'Cristo Re' Hospital   (Italy)

^c S EUGENIO HOSPITAL   (Italy)

^d NONE   (Italy)

Author keywords

Crohn's disease; Lactulose breath test; Mesalazine; Orocaecal transit time; Treatment

Indexed keywords

LACTULOSE; MESALAZINE;

ADULT; AGED; ARTICLE; BACTERIAL OVERGROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; DRUG TRANSPORT; FEMALE; HUMAN; HYDROGEN BREATH TEST; INTESTINE ABSORPTION; INTESTINE FLORA; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; SLOW RELEASE FORMULATION;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BREATH TESTS; COLITIS; CROHN DISEASE; DELAYED-ACTION PREPARATIONS; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRANSIT; HUMANS; ILEITIS; LACTULOSE; MALE; MESALAMINE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0037249395     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200301000-00012     Document Type: Article

References (20)

1. Summers RW, Anuras S, Green J. Jejunal manometry patterns in health, partial intestinal obstruction and pseudoobstruction. Gastroenterology 1983; 85:1290-1300.
2. Ducrotte P, Konig E, Guillemot F, Guedon C, Lerebours E, Denis P, et al. Jejunal motility during cyclic total parenteral nutrition in patients with Crohn's disease. Gut 1989; 30:815-819.
3. Annese V, Bassotti G, Napolitano G, Usai P, Andriulli A, Vantrappen G. Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol 1997; 32:1107-1117.
4. Gotze H, Ptok A. Orocaecal transit time in patients with Crohn's disease. Eur J Pediatr 1993; 152:193-196.
5. Castiglione F, del Vecchio Blanco G, Rispo A, Petrelli G, Amalfi G, Cozzolino A, et al. Orocecal transit time and bacterial overgrowth in patients with Crohn's disease. J Clin Gastroenterol 2000; 31:63-66.
6. Bond JJ, Levitt MD. Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med 1975; 85:546-555.
7. Papa A, Tursi A, Cammarota G, Certo M, Cuoco L, Montalto M, et al. Effect of moderate and heavy alcohol consumption on intestinal transit time. Panminerva Med 1998; 40:183-185.
8. Papa A, Cammarota G, Tursi A, Certo M, Montalto M, De Rosa G, et al. Effects of propylthiouracil on intestinal transit time and symptoms in hyperthyroid patients. Hepato-gastroenterology 1997; 14:126-129.
9. Certo M, Papa A, Montalto M, Tursi A, Cammarota G, Trua F, et al. Orocecal transit time in adult patients with Crohn's disease [abstract]. Ital J Gastroenterol 1995; 27 (suppl 1):60.
10. Kornbluth A, Salomon P, Sachard DB. Crohn's disease. In: Sleisenger MH, Fordtrand JS, eds. Gastrointestinal disease, 5th ed. Philadelphia: WB Saunders; 1993. pp. 1270-1304.
11. Best WR, Becktel JM, Singleton JW, Kearn F. Development of Crohn's disease activity index: national cooperative Crohn's disease study. Gastroenterology 1976; 70:439-444.
12. Hirikawa M, Iida M, Korogi N, Fujishima M. Hydrogen breath test assessment of oro-cecal transit time: comparison with barium meal study. Am J Gastroenterol 1988; 83:1361-1363.
13. Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1988; 95:982-988.
14. De Vos M. Clinical pharmacokinetics of slow release mesalazine. Clin Pharmacokinet 2000; 39:85-97.
15. Annese V, Bassotti G, Napolitano G, Frusciante V, Bruno M, Conoscitore P, et al. Gastric emptying of solids in patients with nonobstructive Crohn's Disease is sometimes delayed. J Clin Gastroenterol 1995; 21:279-282.
16. Keller J, Runzi M, Goebell H, Layer P. Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic response to a meal. Am J Physiol 1997; 272:632-637.
17. Koch TR, Roddy DR, Go VL. Abnormalities of fasting serum concentrations of peptide YY in the idiopathic inflammatory bowel diseases. Am J Gastroenterol 1987; 82:321-326.
18. Scheiber S, Hamling J, Zehnter E, Howaldt S, Daerr W, Raedler A, et al. Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate. Gut 1997; 40:761-766.
19. Miller MA, Parkman HP, Urbain JL, Brown KLT Donohue D J, Knight LC, et al. Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: lactulose accelerates small bowel transit. Dig Dis Sci 1997; 42:10-18.
20. Ternent CA, Thorson AG, Blatchford GJ, Christensen MA, Thompson JS, Lanspa SJ, et al. Mouth to pouch transit after restorative proctocolectomy: hydrogen breath analysis correlates with scintigraphy. Am J Gastroenterol 2001; 96:1460-1463.